Healthcare Co.,Ltd. (SHA:603313)
China · Delayed Price · Currency is CNY 6.64
-0.10 (-1.48%)
Sep 1, 2026, 3:00 PM CST
Healthcare Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -116.12 | -9.82 | -151.42 | 106.6 | 41.36 | -275.53 |
Depreciation & Amortization | 505.36 | 543.36 | 557.23 | 505.67 | 444.06 | 360.07 |
Other Amortization | 130.8 | 165.24 | 179.26 | 136.55 | 97.86 | 80.25 |
Loss (Gain) From Sale of Assets | 1.28 | 0.51 | -14.96 | -0.87 | 0.4 | 0.5 |
Asset Writedown & Restructuring Costs | 54.31 | 39.38 | 36.79 | 14.67 | 4.72 | 4.76 |
Loss (Gain) From Sale of Investments | -8.12 | -2.27 | 14.85 | 5.5 | -25.92 | -22.09 |
Provision & Write-off of Bad Debts | 19.45 | 41.9 | 374.45 | 81.73 | 39.55 | 80.96 |
Other Operating Activities | 291.25 | 171.18 | 148.24 | 233.75 | 92.19 | 270.66 |
Change in Accounts Receivable | 175.79 | 3.97 | -266.43 | -358.17 | -61.16 | -289.22 |
Change in Inventory | -310.96 | -191.3 | 65.49 | -10.89 | 191.97 | -594.39 |
Change in Accounts Payable | 450.5 | 137.51 | 101.81 | 256.95 | -231.99 | 529.57 |
Change in Other Net Operating Assets | -0.49 | -0.49 | - | - | - | -6.36 |
Operating Cash Flow | 1,180 | 883.07 | 963.9 | 916.62 | 565.39 | 67.92 |
Operating Cash Flow Growth | 18.05% | -8.39% | 5.16% | 62.12% | 732.41% | -88.34% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -408.27 | -386.25 | -379.33 | -414.53 | -631.07 | -539.44 |
Sale of Property, Plant & Equipment | 1.71 | 1.79 | 71.93 | 3.98 | 15.74 | 9.81 |
Cash Acquisitions | 0 | -2.71 | -4.03 | - | - | - |
Divestitures | - | - | - | 52.4 | 37.83 | - |
Investment in Securities | 99.44 | 92.25 | -72.37 | 2.25 | 18.03 | -16 |
Other Investing Activities | -80.28 | -83.27 | -11.29 | -7 | 10.48 | 24.61 |
Investing Cash Flow | -387.41 | -378.2 | -395.1 | -362.9 | -548.89 | -523.5 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 795.03 | 40 |
Long-Term Debt Issued | - | 3,649 | 3,043 | 3,356 | 3,410 | 3,402 |
Total Debt Issued | 4,017 | 3,649 | 3,043 | 3,356 | 4,205 | 3,442 |
Long-Term Debt Repaid | - | -3,915 | -3,679 | -4,049 | -4,555 | -2,690 |
Net Debt Issued (Repaid) | -387.03 | -266.25 | -636.09 | -692.11 | -350.12 | 751.47 |
Issuance of Common Stock | - | - | - | 789.19 | - | - |
Repurchase of Common Stock | -97.61 | -166.67 | - | - | -6.94 | -6.44 |
Common Dividends Paid | -90.49 | -109.77 | -125.82 | -151.76 | -135.52 | -258.37 |
Other Financing Activities | -294.26 | -145.49 | -16.44 | -53.57 | -18.44 | -123.09 |
Financing Cash Flow | -869.4 | -688.19 | -778.35 | -108.25 | -511.02 | 363.57 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -112.18 | 89.78 | 24.54 | 91.76 | 170.2 | -192.26 |
Net Cash Flow | -188.73 | -93.54 | -185.01 | 537.23 | -324.32 | -284.27 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 771.98 | 496.82 | 584.57 | 502.1 | -65.68 | -471.52 |
Free Cash Flow Growth | 19.17% | -15.01% | 16.43% | - | - | - |
Free Cash Flow Margin | 8.34% | 5.58% | 6.92% | 6.30% | -0.82% | -5.79% |
Free Cash Flow Per Share | 1.64 | 1.01 | 1.04 | 1.04 | -0.14 | -0.97 |
Levered Free Cash Flow | 540.98 | 295.6 | 741.35 | 424.38 | -355.18 | -414.99 |
Unlevered Free Cash Flow | 587.16 | 387.5 | 855.09 | 558.15 | -241.24 | -327.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 56.81 | 131.29 | 71.38 | 14.31 | -22.13 | -317.37 |
Change in Working Capital | 302.03 | -66.41 | -180.54 | -166.97 | -128.83 | -431.65 |